Search

Xencor Inc

Chiusa

SettoreSettore sanitario

26.58 0.57

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

26.58

Massimo

26.73

Metriche Chiave

By Trading Economics

Entrata

107M

-22M

Vendite

47M

51M

EPS

-0.29

Margine di Profitto

-42.422

Dipendenti

260

EBITDA

109M

-12M

Raccomandazioni

By TipRanks

Raccomandazioni

Fortemente da comprare

Previsioni per 12 mesi

+16.5% upside

Dividendi

By Acuity

Utili prossimi

3 nov 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

589M

2B

Apertura precedente

26.01

Chiusura precedente

26.58

Notizie sul Sentiment di mercato

By Acuity

50%

50%

131 / 339 Classifica in Healthcare

Xencor Inc Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

4 set 2026, 20:07 UTC

Xencor Inc shares are higher, recovering from earlier losses amid broader market selling pressure following a strong jobs report. No specific news was identified.

3 set 2026, 22:15 UTC

News

Shares lower in after-market trading after JP Morgan's rating.

2 set 2026, 20:08 UTC

Xencor Inc shares are lower today, reversing from an early gain amid a weaker-than-expected ADP employment report affecting investor sentiment on interest rates.

1 set 2026, 23:01 UTC

Xencor Inc shares are lower in after-market hours, with no specific news identified. This decline occurs amid broader market concerns over economic growth data.

31 ago 2026, 20:03 UTC

Xencor Inc shares are higher today, supported by strong trading volume. The stock is above its 20-day moving average and near its one-month range high.

28 ago 2026, 20:02 UTC

Xencor Inc shares are lower today, breaking a trend of higher closes. The decline occurs amid rising U.S. Treasury yields and high trading volume.

27 ago 2026, 20:07 UTC

Xencor Inc shares are higher today, recovering from an early dip. The stock is trading well above its 20-day moving average.

26 ago 2026, 23:01 UTC

Xencor Inc shares are lower in after-market trading amid overall market declines. No specific news was identified to explain the stock's movement.

25 ago 2026, 19:36 UTC

Xencor Inc shares are higher, supported by declining crude oil prices and lower Treasury yields. The stock remains above its 20-day moving average.

24 ago 2026, 19:46 UTC

Xencor Inc's shares are higher Monday, rebounding from an earlier low amid rising oil prices and geopolitical tensions, despite no specific company news.

21 ago 2026, 21:41 UTC

Xencor Inc shares are higher in after-market trading, following a recent trend that shows a 44% increase over the past month.

20 ago 2026, 19:56 UTC

Correlated Moves

Xencor Inc shares declined during Thursday's session amid broader sector weakness, influenced by negative sentiment following Walmart's disappointing earnings report.

19 ago 2026, 20:03 UTC

Xencor Inc shares are higher during Wednesday's session, driven by strong market performance and high trading volume. No specific news was identified to explain the move.

18 ago 2026, 20:03 UTC

Xencor Inc shares are trading higher today, supported by strong upward momentum and unusually high market volume. No specific news was identified for the movement.

17 ago 2026, 19:26 UTC

Social Media

Xencor Inc shares are lower despite increased institutional interest, including Johnson & Johnson's $12 million acquisition of 748,062 shares.

14 ago 2026, 19:16 UTC

Shares of Xencor Inc. are modestly higher amid cautious broader market sentiment following a decline in U.S. retail sales for July.

13 ago 2026, 19:21 UTC

Xencor Inc shares are lower today, with no specific news driving the decline. High trading volume suggests increased activity amid routine fluctuations.

12 ago 2026, 19:56 UTC

Social Media

Xencor Inc shares are higher, supported by social media discussions valuing the company at $1.3 billion based on its ENPP3 asset potential.

11 ago 2026, 19:26 UTC

Xencor Inc shares are advancing, continuing a four-session trend. Investors are focused on upcoming inflation reports that may influence market sentiment.

10 ago 2026, 19:31 UTC

News

Xencor Inc shares are higher today, buoyed by increased institutional investments from Dimensional Fund Advisors and BVF Inc. IL.

7 ago 2026, 23:16 UTC

Xencor Inc shares are higher in after-market trading, supported by decreased interest rate hike expectations following a Labor Department report on non-farm payrolls.

6 ago 2026, 20:03 UTC

News

Xencor shares are higher as Cantor Fitzgerald raises its price target to $44, reflecting confidence in the company's pipeline and upcoming ESMO Congress presentation.

3 ago 2026, 19:51 UTC

Xencor Inc's shares are declining, continuing a downward trend since Friday's close, despite a broader market rally in technology and airlines.

31 lug 2026, 20:03 UTC

Xencor Inc shares are lower, reversing earlier gains amid rising US Treasury yields and crude oil prices, contributing to inflation concerns and interest rate expectations.

30 lug 2026, 19:03 UTC

News
Social Media

Xencor Inc. gains following a $105 million settlement with Alexion, boosting investor confidence and extending its operating runway through 2028.

29 lug 2026, 19:36 UTC

Xencor Inc. shares are lower as broader market trends decline ahead of the Federal Reserve's policy announcement, amid rising oil prices and inflation concerns.

28 lug 2026, 20:07 UTC

Xencor Inc is gaining amid a strong Biotechnology sector, despite earlier declines. The stock has rebounded to settle near the upper end of its one-month range.

27 lug 2026, 19:11 UTC

Xencor Inc shares are higher today, reflecting a positive market environment despite earlier intraday pullbacks. No specific news was identified to explain the movement.

24 lug 2026, 19:11 UTC

Xencor Inc shares are lower in Friday's session, reflecting broader market trends. No specific news was identified to explain the price movement.

22 lug 2026, 20:06 UTC

Xencor Inc shares are lower today, retracing from an earlier peak. Broader market sentiment is affected by uncertainty ahead of the Federal Reserve meeting.

Confronto tra pari

Modifica del prezzo

Xencor Inc Previsione

Obiettivo di Prezzo

By TipRanks

16.5% in crescita

Previsioni per 12 mesi

Media 31 USD  16.5%

Alto 46 USD

Basso 20 USD

Basato su 12 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Xencor Inc - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Fortemente da comprare

12 ratings

10

Acquista

2

Mantieni

0

Vendi

Sentiment

By Acuity

131 / 339 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Xencor Inc

Xencor, Inc. is a clinical-stage biopharmaceutical company that is focused on discovering and developing engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The Company uses its engineering capabilities to enable its understanding of protein structure and interactions to design XmAb technologies and develop candidates with properties. Its antibody design is focused on the segment of antibodies that interact with target antigens. It is focused on the Fc domain, which is the part of an antibody that interacts with various segments of the immune system and controls antibody structure. The Fc domain is constant and interchangeable among antibodies, and its engineered Fc domains are the XmAb technology, which can be readily substituted for natural Fc domains. Its drug candidates include Plamotamab, XmAb717, Vibecotamab, Tidutamab, XmAb841, XmAb104, XmAb306, XmAb104, XmAb564 and XmAb698.
help-icon Live chat